**Core Concept:**
Arginosuccinate synthase is an enzyme involved in the urea cycle, specifically in the conversion of citrulline and fumarate to arginosuccinate. This cycle plays a crucial role in the catabolism of ammonia, maintaining the balance of nitrogenous waste products and producing essential amino acids.

**Why the Correct Answer is Right:**
Deficiency of arginosuccinate synthase leads to a blockage in the urea cycle, specifically in the production of arginosuccinate from citrulline and fumarate. This results in the accumulation of intermediary compounds like citrulline and fumarate, leading to hypercitrullinemia and hyperfumaratemia. Patients with this deficiency may present with hyperammonemia, seizures, and neurological dysfunction, collectively known as neonatal-onset multiple enzyme deficiency (NOMED).

**Why Each Wrong Option is Incorrect:**
A. Deficiency of ornithine transcarbamylase (OTC) is the correct answer for the urea cycle disorder causing hyperammonemia. OTC deficiency leads to a downstream deficiency in the cycle, causing the accumulation of intermediary compounds like ornithine and urea.
B. Deficiency of argininosuccinate lyase (ALS) is another correct answer for the urea cycle disorder causing hyperammonemia. ALS deficiency blocks the pathway at the stage of arginosuccinate formation, leading to hyperammonemia and neurological symptoms.
C. Deficiency of arginase is not the correct answer as it occurs in the third step of the urea cycle, causing an accumulation of arginine.
D. Deficiency of argininosuccinate synthetase (ASS) is not the correct answer as it occurs in the first step of the urea cycle, leading to a block in the pathway before arginosuccinate formation.

**Clinical Pearl:**
The correct answer, deficiency of arginosuccinate lyase (ALS), is an example of a multiple enzyme deficiency affecting the urea cycle, which is essential for maintaining ammonia homeostasis in the body. Patients with ALS deficiency often present with neurological symptoms, seizures, and developmental delay, highlighting the importance of a comprehensive evaluation of the urea cycle in patients with neurological dysfunction and hyperammonemia.